Intelligent Medicine Acquisition Corp.

Intelligent Medicine Acquisition Corp. (Nasdaq: IQMD) is a blank-check company focused on the healthcare and life sciences sector that registered for its initial public offering via an S-1 filing submitted to the SEC on October 13, 2021. The vehicle was formed to identify and complete a merger or acquisition with one or more businesses operating in the intelligent medicine or adjacent healthcare technology space, reflecting the broad wave of sector-specific SPACs that came to market during the 2021 peak cycle. For comprehensive filing history, deal-stage tracking, sponsor profiles, and comparable SPAC analytics, sign up for full data access at SpacDesk.